Even as a dominant braking control of Nrf2 activity, Nrf1α may play an essential role for ’decision-maker’ or ‘executor’ in the cell senescence and cancer progression, since a secretory phenotype of senescent cells occurs by a Nrf2-independent mechanism [95], albeit the relevance to Nrf1 needs to be verified. This evidence concerns the gene NFE2L2 and cancer.